Focus on Psychosis
Section Editor
Ann K. Shinn, MD, MPH
The objective of the Focus on Psychosis section is to promote scientific research that impacts the clinical care of individuals with psychotic disorders and related conditions. Topics may pertain to conditions across the continuum of psychosis (eg, disorders in the schizophrenia spectrum or psychosis in mood and other psychiatric disorders) and at any stage of illness (eg, high-risk, first-episode, chronic, and in recovery). We are especially interested in high-quality manuscripts describing well-designed and well-conducted studies relating to pharmacologic, somatic, psychosocial, cognitive, and complementary therapies. While basic and translational research studies in psychosis are not the focus of the journal, we strongly welcome studies that incorporate biological measures as a clinical outcome and/or that elucidate biological mechanisms associated with specific clinical outcomes.
Please contact Ann K. Shinn, MD, MPH, at [email protected].
We encourage authors to submit papers for consideration as a part of our Focus on Psychosis section.
Recent Special Section Articles
Original Research
Severity of Antipsychotic-Induced Cervical Dystonia by Algorithm-Based Rating System
April 15, 2024
Rater consensus data were compared with deviation angle data using AI-based deviation angle measurement technology. With the range of tilt angles found in the study, the authors propose a…
Original Research
Generalizability of RCTs in First-Episode Schizophrenia
March 29, 2023
First-episode schizophrenia patients with suicidal ideation and substance use disorder are often excluded from clinical trials. Omitting them does not affect key outcome measures but excludes many potential subjects.
